个人简历

1996.9-2001.7，华中科技大学同济医学院获临床医学学士学位\r
2001.9-2004.7，华中科技大学同济医学院获肿瘤学硕士学位\r
2004.9-2007.7，华中科技大学同济医学院获外科学博士学位\r
2007.7-2013.9，华中科技大学同济医学院附属同济医院泌尿外科主治医师\r
2013.10至今，华中科技大学同济医学院附属同济医院泌尿外科副主任医师（副教授），硕士研究生导师\r
2010.4-2010.6，美国加州大学旧金山分校UCSF短期访问学者，并参加美国住院医师培训项目\r
2012.3-2013.6，以访问学者身份在美国西北大学学习，师从世界著名泌尿外科专家CATALONA教授（“前列腺PSA之父”），临床上专门研修泌尿系肿瘤的微创手术治疗及晚期肿瘤的综合治疗，同时在Dr. Lee（Chung Lee）实验室从事科研工作一年，曾参与两个前列腺癌重大专项课题SPORE研究\r
2015.5-2015.6，美国西部癌症中心—CITY OF HOPE参加机器人辅助腹腔镜操作技术临床培训，并获得机器人操作培训证书

研究领域

"""""微创泌尿外科，泌尿系肿瘤"

近期论文

TianJianbo,WangZhihua,Mei Shufang et al. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.[J] .Nucleic Acids Res., 2019, 47: D909-D916.\r
\r
XiaoJun,WangMeng,He Wei et al. Does Postoperative Rehabilitation for Radical Cystectomy Call for Enhanced Recovery after Surgery? A Systematic Review and Meta-analysis.[J] .Curr Med Sci, 2019, 39: 99-110.\r
\r
Zhou Hui,Wu Guanqing,Ma Xueyou et al. Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways.[J] .J. Exp. Clin. Cancer Res., 2018, 37: 89.\r
\r
Yang Chunguang,Ma Xueyou,Wang Zhihua et al. Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation.[J] .Drug Des Devel Ther, 2017, 11: 431-439.\r
\r
Bladder neck preservation improves time to continence after radical prostatectomy: a systematic review and meta-analysis. Oncotarget. doi: 10.18632/oncotarget.11997.\r
\r
Transferrin receptor monoclonal antibody exacerbates curcumin-mediated apoptotic effect in castration resistant prostate cancer cells. International Journal of Clinical and Experimental Pathology.2016;9(5):5306-12.\r
\r
Knockdown of GRP78/Bip expression by asymmetric siRNA induces prostate cancer cells undergoing apoptosis along with attenuated capability for migration. Molecular Medicine Reports.2015;11(1):249-56.\r
\r
Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Disease. 2014;17(2):119-25.\r
\r
Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein. BMC Biotechnology.2012, 12:91.